Back to drug safety directory
HMG-CoA reductase inhibitor (statin)Reviewed May 16, 2026

Atorvastatin (Lipitor) and Ketamine Therapy | Tovani Health

Lipitor (Atorvastatin)HMG-CoA reductase inhibitor (statin)

Verdict at Tovani Health

Fully compatible; no meaningful interaction with ketamine.

Atorvastatin and ketamine have no clinically significant interaction. Statins are commonly on board for KAP patients with cardiovascular risk and do not change session planning.

If you take Lipitor regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.

How Lipitor interacts with ketamine

Atorvastatin inhibits cholesterol synthesis in the liver. No overlap with ketamine pharmacology.

What we do at intake

Continue as normal. Disclose if you have unexplained muscle pain (statin myopathy is rare but separate from KAP).

Bottom line

Atorvastatin and ketamine have no clinically significant interaction. Statins are commonly on board for KAP patients with cardiovascular risk and do not change session planning.

Frequently Asked Questions

Does my statin affect ketamine metabolism?

Atorvastatin is a weak CYP3A4 substrate; the impact on ketamine is negligible.

Ready to find out if at-home ketamine fits your situation?

We’ll note that you’re on Lipitor (Atorvastatin) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.

FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.

Sources

The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.

  1. Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy. Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI.. Clinical Pharmacokinetics. 2016. PMID: 27028535

    Comprehensive clinical pharmacokinetics/pharmacodynamics review of ketamine including CYP-mediated drug interactions (CYP3A4, CYP2B6).

Clinically reviewed

Reviewed by Benjamin Soffer, DO on May 16, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.

This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.